STOCK TITAN

AbbVie Launches Love in Mind™ to Spotlight the Emotional Impact of Migraine on Romantic Relationships

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

AbbVie (NYSE: ABBV) launched Love in Mind™ on January 29, 2026, an educational initiative about the emotional impact of migraine on dating and romantic relationships. A Harris Poll of 606 adults found 89% struggle to be present, 51% canceled dates (avg. 8 times/year), and 78% push past pain to be intimate. Country artist Jessie James Decker shares her personal experience; relationship guidance is offered by Nedra Glover Tawwab. Resources and full survey findings are available at LoveInMind.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+0.80%
1 alert
+0.80% News Effect

On the day this news was published, ABBV gained 0.80%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Migraine prevalence: nearly 40 million Americans Survey sample size: 606 adults Impact on relationships: 3 out of 4 respondents +4 more
7 metrics
Migraine prevalence nearly 40 million Americans Number of Americans affected by migraine
Survey sample size 606 adults Love in Mind survey respondents living with migraine
Impact on relationships 3 out of 4 respondents Reported migraine attacks stood in the way of romantic relationships
Difficulty being present 89% of respondents Agreed it is hard to feel present in a romantic relationship during an attack
Cancelled or rescheduled dates 51% of respondents Have cancelled or rescheduled a date due to migraine attacks
Cancellations per year 8 times Average number of dates cancelled or rescheduled in past 12 months
Pushing past pain for intimacy 78% of respondents Sometimes try to push past migraine pain to be more physically intimate

Market Reality Check

Price: $223.74 Vol: Volume 4,910,771 vs 20-da...
normal vol
$223.74 Last Close
Volume Volume 4,910,771 vs 20-day average 6,911,028 (relative volume 0.71) ahead of this release. normal
Technical Price 218.67 trading above 200-day MA 207.97 before the news.

Peers on Argus

ABBV was down 2.35% while key peers showed mixed, smaller moves (e.g., JNJ +0.58...

ABBV was down 2.35% while key peers showed mixed, smaller moves (e.g., JNJ +0.58%, NVO -1.87%), suggesting a stock-specific move rather than a broad sector trend.

Historical Context

5 past events · Latest: Jan 16 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Jan 16 Phase 3 data update Positive -1.1% Epcoritamab Phase 3 trial showed improved PFS but no OS benefit.
Jan 12 Access/pricing agreement Positive +0.3% Three-year U.S. agreement on access, affordability and large R&D investment.
Jan 12 Licensing deal Positive -0.0% Exclusive license for RC148 bispecific antibody with large upfront and milestones.
Jan 12 Manufacturing acquisition Neutral -0.0% Acquisition of Arizona device facility to expand U.S. manufacturing capacity.
Jan 12 Supply rights deal Neutral -0.0% West sells SmartDose 3.5mL manufacturing and supply rights to AbbVie.
Pattern Detected

Recent news shows a mix of strategic deals and clinical data where positive or strategic announcements have not always been followed by positive price reactions.

Recent Company History

Over the past months, AbbVie has reported major R&D and business developments. On Jan 16, 2026, Phase 3 data for epcoritamab in DLBCL showed improved PFS but no clear OS benefit, and the stock moved -1.11%. On Jan 12, 2026, multiple strategic announcements—including a U.S. access agreement, a large bispecific antibody licensing deal, and a U.S. manufacturing expansion—produced modest price reactions ranging from -0.02% to +0.32%. Against this backdrop, today’s migraine-focused educational initiative fits into AbbVie’s broader efforts to support disease awareness alongside its clinical and commercial activities.

Market Pulse Summary

This announcement launches an educational initiative highlighting the emotional and relational burde...
Analysis

This announcement launches an educational initiative highlighting the emotional and relational burden of migraine, with survey data from 606 adults and prevalence estimates of nearly 40 million Americans affected. It complements AbbVie’s recent stream of clinical and strategic updates rather than altering financial guidance. Investors may track how such disease-awareness efforts integrate with the company’s broader migraine portfolio, while also monitoring future clinical results and regulatory disclosures for direct financial implications.

AI-generated analysis. Not financial advice.

  • ~3 out of 4 respondents said migraine attacks have stood in the way of romantic relationships, according to new Harris Poll survey
  • Wife, mother, country music star, and entrepreneur Jessie James Decker shares her personal experience living with migraine
  • Love in Mind encourages candid conversations about migraine with healthcare providers to develop a personalized care plan

NORTH CHICAGO, Ill., Jan. 29, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today the launch of Love in Mind™, an educational initiative that seeks to elevate the conversation about the emotional impact of living with migraine, beyond the physical symptoms, with a focus on dating and romantic relationships. Migraine is more than just a headache. It is an underdiagnosed, undertreated neurological disease that can cause debilitating pain affecting nearly 40 million Americans.1,2

When Migraine Meets Romance

The Love in Mind survey,3 conducted online by Harris Poll on behalf of AbbVie, took a closer look at how migraine can affect the emotional, social, and romantic lives of 606 adults living with the disease. A few of the key survey findings include:   

  • Most survey respondents (89%) agreed* it's hard to feel present in a romantic relationship when experiencing a migraine attack; a reminder that migraine can extend beyond physical symptoms.
  • Love often takes a rain check. More than half (51%) of survey respondents have cancelled or rescheduled a date due to migraine attacks. On average, they have done so eight times in the past twelve months.
  • Behind closed doors, the struggle to maintain intimacy can be a challenge. Of those surveyed, 78% of respondents agreed* they sometimes try to push past the pain of migraine attacks to be more physically intimate.

*Agree responses include both "strongly agree" and "somewhat agree."

"These survey results highlight how migraine can extend beyond the physical to affect the relationships and moments that matter most, including how we pursue relationships, maintain connection, and view ourselves as romantic partners," said Aubrey Adams, PhD, therapeutic area head, migraine, medical affairs, AbbVie. "Understanding and acknowledging these impacts is an important part of managing migraine. Open conversations with a healthcare provider about how migraine truly affects daily life – relationships, confidence, and sense of self – can be a meaningful step toward comprehensive care."

Country Music Star and Entrepreneur Jessie James Decker Pulls Back the Curtain on Living with Migraine

Jessie James Decker remembers having what she now knows as migraine symptoms as early as middle school before receiving an official diagnosis years later. Beyond the physical symptoms, she has first-hand experience with the emotional toll migraine can have on relationships and is passionate about sharing her migraine story and spreading awareness to help others.

"I want to be fully present, but with migraine, that's not always easy. I remember powering through the pain of migraine to attend my husband's football games, despite knowing the lights and noise would trigger me, because I didn't want to feel like I was missing special moments," said Jessie. "Over the years, I've been completely honest with my doctor about how my migraine affects the moments that matter most to me so we can continue to fine-tune my management plan. I encourage anyone living with migraine to do the same. While I still live with migraine, with my care plan, I feel I am able to show up best for myself and those I love."  

Jessie's experience reflects how migraine can influence even the most meaningful relationships. Building on this perspective, relationship expert, licensed therapist, and New York Times best-selling author Nedra Glover Tawwab offers guidance for those living with migraine on how to navigate relationship dynamics, including prioritizing open communication, practicing self-compassion, and managing expectations with your partner.

Visit www.LoveInMind.com to learn more about migraine, find additional Love in Mind survey findings about how migraine can impact love and relationships, learn more about Jessie's story, and discover relationship tips from Nedra, along with additional migraine resources.

About the Love in Mind Survey
The Love in Mind survey explored how migraine can affect the emotional, social, and romantic lives of adults living with the disease, including its impact on dating, emotional connection, communication, and physical intimacy. The survey was conducted online in the U.S. by The Harris Poll on behalf of AbbVie between Sept. 11 – 25, 2025, among 606 U.S. adults 18+ diagnosed with migraine.

About AbbVie in Migraine
AbbVie is the only company with three prescription treatments designed to meet patient needs across the full spectrum of migraine, a debilitating disease. We are committed to empowering people in their pursuit of migraine freedom. We advance science that enables healthcare professionals to care for people impacted across the spectrum of migraine. Through education, research and partnerships with the migraine community, we strive to help those with migraine navigate barriers to care, access effective treatments and reduce the impact of migraine on their lives.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

Media Contact:
Jacqueline Karis
310-486-4993
Jacqueline.karis@abbvie.com

References:

  1. American Migraine Foundation. What is migraine? January 21, 2021. Accessed January 31, 2024. https://americanmigrainefoundation.org/resource-library/what-is-migraine/
  2. The American Migraine Foundation. Migraine Facts Accessed July 8, 2025. Available at: https://americanmigrainefoundation.org/resource-library/migraine-facts/
  3. Data on file. The Love in Mind survey was conducted online in the U.S. by The Harris Poll on behalf of AbbVie between Sept. 11 - 25, 2025, among 606 U.S. adults aged 18+ diagnosed with migraine.

 

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-launches-love-in-mind-to-spotlight-the-emotional-impact-of-migraine-on-romantic-relationships-302673336.html

SOURCE AbbVie

FAQ

What did AbbVie announce with the Love in Mind initiative (ABBV) on January 29, 2026?

AbbVie launched Love in Mind, an educational program addressing migraine's emotional impact on relationships. According to the company, the initiative includes survey findings, personal stories from Jessie James Decker, relationship guidance, and resources at LoveInMind.com to support people living with migraine.

What were the key Harris Poll findings about migraine and romantic relationships in the ABBV survey?

The Harris Poll of 606 adults reported high relationship impacts from migraine. According to the company, 89% said it's hard to feel present, 51% canceled or rescheduled dates (avg. eight times/year), and 78% sometimes push past pain for intimacy.

How does Jessie James Decker contribute to AbbVie's Love in Mind campaign (ABBV)?

Jessie James Decker shares her firsthand experience living with migraine to raise awareness and normalize conversations. According to the company, her story highlights diagnosis delays, the emotional toll on relationships, and how tailored care plans helped her manage symptoms and remain present for key moments.

What relationship advice does Love in Mind (ABBV) provide for people with migraine?

The campaign emphasizes open communication, self-compassion, and expectation management with partners. According to the company, licensed therapist Nedra Glover Tawwab offers guidance on navigating intimacy, discussing triggers, and collaborating with healthcare providers to develop personalized care plans.

Where can patients and caregivers find the Love in Mind survey results and resources from AbbVie (ABBV)?

Survey results, personal stories, and relationship resources are available at the campaign website. According to the company, visitors should go to LoveInMind.com for full Harris Poll findings, Jessie James Decker’s story, expert tips, and tools to support conversations with healthcare providers.
Abbvie Inc

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Latest SEC Filings

ABBV Stock Data

387.09B
1.77B
0.1%
74.6%
0.87%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NORTH CHICAGO